Li F, Iseki E, Odawara T, Kosaka K, Yagishita S, Amano N
Department of Psychiatry, Yokohama City University School of Medicine, Japan.
J Neurol Sci. 1998 Jul 15;159(1):73-81. doi: 10.1016/s0022-510x(98)00136-1.
In patients with progressive supranuclear palsy (PSP), various tau-positive abnormal structures are found in the cerebral cortex as well as in the subcortical nuclei. Similar tau-positive abnormalities are also identified in cortico-basal degeneration (CBD). It is therefore questionable as to whether PSP can be neuropathologically differentiated from CBD. It also remains nuclear whether neurofibrillary tangles (NFT) in the cerebral cortex of PSP patients consist of PSP-NFT or concomitant Alzheimer's disease (AD)-NFT, although there have been some reports suggesting that PSP- and AD-NFT are different with respect to distribution pattern and biochemical character. In this study, a regional quantitative analysis of the distribution and antigenicity of tau-positive neurons (TPN) was performed in PSP cases and compared with that in AD cases. TPN consisted of NFT with tangle-formation and pretangle neurons (PN) without tangle-formation. In addition, NFT were subdivided into mature and immature NFT according to the difference of staining properties with anti-tau-related antibodies. The comparison of the TPN of the PSP cases with those of the AD cases revealed that the degree of tangle-formation in the TPN of AD was similar in all of the examined regions, while that in the TPN of PSP varied according to the region and case. Moreover, the NFT in the PSP and AD cases had different distributions according to the cortical layer and subnucleus, even in the common predilection sites of PSP and AD, suggesting that NFT in these regions of the PSP cases consist mainly of PSP-NFT. In addition, the PSP cases could be divided into two groups according to the difference of the tangle-formation of TPN; group I with typical PSP pathology and group II with atypical PSP pathology similar to CBD. This suggests that there is a continuity between PSP and CBD with respect to the distribution and antigenicity of TPN.
在进行性核上性麻痹(PSP)患者中,大脑皮质以及皮质下核团中可发现各种tau蛋白阳性异常结构。在皮质基底节变性(CBD)中也可识别出类似的tau蛋白阳性异常。因此,PSP在神经病理学上是否能与CBD区分开来存在疑问。尽管有一些报告表明PSP神经纤维缠结(NFT)和阿尔茨海默病(AD)-NFT在分布模式和生化特征方面有所不同,但PSP患者大脑皮质中的NFT究竟是由PSP-NFT还是合并的AD-NFT组成也仍不明确。在本研究中,对PSP病例中tau蛋白阳性神经元(TPN)的分布和抗原性进行了区域定量分析,并与AD病例进行了比较。TPN包括形成缠结的NFT和未形成缠结的前缠结神经元(PN)。此外,根据抗tau相关抗体染色特性的差异,NFT可细分为成熟和不成熟NFT。PSP病例与AD病例的TPN比较显示,AD的TPN中缠结形成程度在所有检查区域相似,而PSP的TPN中缠结形成程度因区域和病例而异。此外,即使在PSP和AD的共同好发部位,PSP和AD病例中的NFT根据皮质层和亚核的不同也有不同分布,这表明PSP病例这些区域的NFT主要由PSP-NFT组成。此外,PSP病例可根据TPN缠结形成的差异分为两组;I组具有典型的PSP病理特征,II组具有与CBD相似的非典型PSP病理特征。这表明在TPN的分布和抗原性方面,PSP和CBD之间存在连续性。